FOSBAC PLUS T

Works where other fail
Lowers mortality.
Reduces disease incidence.
Improves feed conversion.
Evens out ock’s uniformity.
Tempers post-vaccination reactions.

FOSBAC
WORLD CLASS ANTIBIOTIC
PLUS T
FOSBAC PLUS T is an energizing, broad spectrum
antibiotic compound that was developed to optimize
animal’s economic performance through Strategic
Application Programs.
COMPONENTS:
FOSOMYCIN is a member of the phosphonic acid group FRUCTOSE 1.6 DIPHOSPHATE: is a carbohydrate natu-
of antibiotics. It has a broad spectrum range of action. It rally produced by the animal’s organism. Fructose 1.6
acts against both Gram positive and Gram negative Diphosphate plays an extremely important triple-role:
microorganisms. It potentiates Fosfomycin a stunning 6 to 10 folds.
fosfomycin is a bactericidal agent against both aerobes It renders resistance buildup to Fosfomycin highly
and anaerobes as well. Bedson was the rst laboratory improbable.
worldwide to develop the use and application of fosfo- It provides bio-energy.
mycin for the veterinary industry.
ELECTROLYTES: play an important role in the rehydra- TYLOSIN: is a macrolide, bacteriostatic antibiotic, effec-
tion process of sick birds that are affected by hydro-elec- tive against Gram positive and some Gram negative
trolytic disorders due to heat stress, fever and enteric bacteria. It is made naturally by the bacterium Strepto-
diarrhea. myces fradiae.
UNIQUE FEATURES:
what makes FOSBAC PLUS T unique is the fact that
Fosfomycin is Fructose 1.6 Diphosphate in proprietary
synthesis, in such a “Trojan Horse” approach to antibi-
otic therapy, whereby bacteria do not recognize the
active site of the antibiotic.
Due to this synergism between the metabolic sugar
and the antibiotic “active ingredient” that comes from
enhanced bacteria uptake, FOSBAC PLUS T eludes
normal bacteria defenses and doesn’t exhibit loss of
sensitivity with extended use in vivo.

COMPONENTS: Each 100 g contains:
STRONG SYNERGISM: good synergistic effects have Calcium Fosfomycin …………………………………….. 20g
been demonstrated over the years between Fosfomy-
Tylosin Tartrate ……………………………………………….. 5g
cin and many other antibiotics.
Fructose 1.6 Diphosphate ……………………………… 18g
PERFECT COMPATIBILITY: no incompatibility has
Sodium Phosphate ……………………………………….. 15g
been found to date between FOSBAC PLUS T and
Magnesium Sulphate Heptahydrate ……………. 10g other water soluble pharmaceuticals and/or feed
additive, normally used for poultry and livestock. Sodium Chloride q.s. ……………………………………. 100g
NO TOXICITY: FOSBAC PLUS T does not from toxic
metabolites. Not metabolized in the liver, it doesn’t

CHARACTERISTICS:
interfere with liver physiology leaving such an
important organ to its normal and vital functioning.

HIGH EFFICACY:
Developed by BEDSON more than 20 year ago,
FOCBAC PLUS T continues to be highly effective at

INDICATION:
original dose level with no observed changes in the
resistance buildup pattern of most microorganisms. Treatment of infections caused by Gram negative and
Gram positive bacteria such as: Escherichia coli,
EXCEPTIONAL ABSORPTION: Salmonella sp., Pasteurella sp., Colibacillosis, infec-
97% of FOSBAC PLUS T is absorbed through the gut. tious Coriza, Fowl Cholera, Staphylococcus sp., Strep-
tococcus sp., Proteus sp., Pseudomonas p., Clostridi-
EXCELLENT DIFFUSABILITY: um sp., Vibrio sp., Haemophilus sp., Citrobacter sp.,
its high solubility and its low molecular weight gives it Klebsiella sp., Shigella sp., Enterobacter spp., Ornitho-
high diffusability even into abscesses and areas of bacterium sp.
poor vascularization.
DOSAGE & ADMINSTRATION:
Bacteria Sensitive
Strategic Medication Programs:
Day(01 to 05): 1g/2 Litres in water for 3 to 5 Days. Haemophilus 100
Day(18 to 21): 1g/4 Litres in water for 3 to 5 Days.
100 Sallmonella
Day(28 to 31): 1g/4 Litres in water for 3 to 5 Days.
98 Pasteurella
Dosage
98 Vibrio
Treatment: 1g /2Litres in water for 3 to 5 Days.
98 Enterobacteria
PACKING: 96 E. coli
FOSBAC PLUS T 95
Clostridium
Available in 160g
Effect of FOSBAC PLUS T (1981-2000) Veterinary Services Labs, & 1kg
South and Central America.